翻訳と辞書 |
Neuronetics
Neuronetics is a privately held company developing non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. The NeuroStar transcranial magnetic stimulation (TMS) therapy system was developed for treating major depression in patients who have not benefitted from prior antidepressant medications. Neuronetics was founded within The Innovation Factory, an Atlanta, GA-based medical technology incubator. The Company has raised venture capital based on its intellectual property portfolio and management team. Neuronetics’ investors include life-sciences firms such as Quaker BioVentures, Three Arch Partners, Investor Growth Capital, Onset Ventures, Interwest Partners, KBL Healthcare Ventures, Accuitive Medical Ventures and New Leaf Venture Partners.〔(www.Neuronetics.com/Investors )〕 On September 1, 2010, the World Economic Forum announced the company as a Technology Pioneer for 2011.〔(Thirty-One Visionary Companies Selected as Technology Pioneers 2011 )〕 ==Products==
Neuronetics' first product, the NeuroStar TMS Therapy System is designed to non-invasively stimulate the brain using highly focused MRI-strength magnetic pulses, or transcranial magnetic stimulation (TMS). NeuroStar delivers therapy that is highly targeted, involving a brain region that is thought to be involved in depression. NeuroStar TMS Therapy is prescribed by a psychiatrist and is delivered in an outpatient setting. The patient sits in the chair and undergoes 40-minute sessions over the course of four to six weeks.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Neuronetics」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|